Saturday 17 October 2026
Export ZBH’s income statement to Excel — free account
Zimmer Biomet Holdings, Inc.
ZBH Healthcare Medical Devices
Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024. In the quarter to June 2026, revenue grew 4.80%, EPS grew 33.8%, free cash flow grew 13.1% and total debt fell 1.23%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five.
95.06
0.68
+0.72%
Follow ZBH
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
6.40% | 5.60% | 6.07% | 6.41% | |
Piotroski F-Score |
6 | 6 | 6 | 6 | |
| 3.56% | 3.17% | 3.39% | 3.53% | ||
ROIC |
4.25% | 3.50% | 3.74% | 3.82% | |
Return on Tangible Assets |
14.31% | 14.87% | 17.66% | 18.67% | |
Average Days of Receivables |
72.82 | 75.58 | 75.03 | 75.91 | |
Free Cash Flow per Share |
5.11 | 5.44 | 5.17 | 5.39 | |
Free Cash Flow |
1,011.30 | 1,077.30 | 1,008.10 | 1,036.50 | |
Capital Expenditures |
(674.70) | (619.80) | (665.60) | (706.80) | |
| Other line items | |||||
Cash ROIC |
4.56% | 5.18% | 4.90% | 5.05% | |
Accounts Receivable Turnover |
5.20 | 5.17 | 5.16 | 5.03 | |
Accounts Payable Turnover |
7.18 | 10.02 | 7.61 | 7.31 | |
Inventory Turnover |
0.94 | 1.10 | 1.12 | 1.09 | |
Average Days of Payables |
50.30 | 44.35 | 52.31 | 50.18 | |
Days of Inventory on Hand |
396.22 | 334.66 | 325.42 | 323.27 | |
Tax Rate |
(0.21) | (0.15) | (0.16) | (0.14) | |
Research and Development Expense of Revenue |
5.60% | 5.57% | 5.37% | 5.20% | |
Selling, General and Administrative Expense of Revenue |
39.09% | 39.57% | 39.82% | 40.34% | |
Share Based Compensation of Revenue |
1.09% | 1.10% | 1.13% | 1.15% | |
Interest Coverage |
4.71 | 3.75 | 3.99 | 4.17 | |
Operating CF/Net income |
2.09 | 2.41 | 2.20 | 2.16 | |
Depreciation/Fixed assets |
0.49 | 0.50 | 0.50 | 0.50 | |
Capex/Depreciation |
(0.63) | (0.57) | (0.60) | (0.64) | |
Revenue per Share |
40.44 | 41.57 | 43.12 | 44.27 | |
Operating CF per Share |
8.51 | 8.57 | 8.58 | 9.07 | |
Capex per Share |
(3.41) | (3.13) | (3.41) | (3.68) | |
Capex to Sales |
0.08 | 0.08 | 0.08 | 0.08 |
Columns are period end dates